|Videos|April 20, 2018

What Makes Elizabethkingia Unique?

Emil Lesho, DO, FACP, FIDSA, FSHEA, explains what makes Elizabethkingia unique.

Emil Lesho, DO, FACP, FIDSA, FSHEA, healthcare epidemiologist in the Infectious Diseases Unit at Rochester Regional Health in Rochester, NY, explains what makes Elizabethkingia unique.

Interview Transcript (modified slightly for readability):

Elizabethkingia anopheles is somewhat unique in that it’s also been isolated from the midgut of the Anopheles mosquito. That’s where it gets its name from. It is mostly a water-borne pathogen. There was a large outbreak involving almost 70 patients and approximately 20 deaths across 3 states, Wisconsin, Illinois, and Michigan. To my knowledge, there was a very thorough outbreak investigation conducted by the Centers for Disease Control and Prevention (CDC) and the Wisconsin Department of Health [where they] investigated all types of sources, including food sources and at the end of 2016, the source remained unidentified. It is associated with water, and all those states are around the Great Lakes. [There could] be some association with that, but, that is pure speculation.

For clinicians, it might be confusing because [the pathogen] underwent 3 name changes. Elizabethkingia is so named after an investigator at the CDC, but that genus was originally named, ‘Flavobacterium.’ Several years ago, that was renamed as Chryseobacterium. Currently, in many of the diagnostic platforms [used] today, the genus is Chryseobacterium, instead of Elizabethkingia.

Elizabethkingia meningoseptica has been found to be associated with outbreaks of meningitis in neonates.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.